Baxter Oncology GmbH (manufacturing, quality control testing at batch release (except cell growth inhibition))
UkraineAll medications by this manufacturer
-
Enhertu
Form: powder for concentrate for infusion solution
Active substance Dosage trastuzumab deruxtecan 100 mg ATC: L01FD04